
A new head-to-head study reveals tirzepatide achieves 47% more weight loss than semaglutide in people with obesity but without diabetes, highlighting its superior effectiveness and cardiometabolic benefits. A groundbreaking new study has revealed that tirzepatide leads to significantly greater weight loss than semaglutide in people living with obesity but without diabetes. Over the course of [...]